{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:59:01Z","timestamp":1777395541363,"version":"3.51.4"},"reference-count":40,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2021,6,29]]},"abstract":"<jats:p>Background: Cerebrospinal fluid (CSF) biomarkers are widely accepted as manifestations of Alzheimer\u2019s disease (AD) pathogenesis and incorporated into biological definition of AD. However, the correlations between CSF and other biomarkers such as neuroimaging and neuropsychiatric evaluation are complicated and inconsistent. Objective: We aimed to better interpreting CSF biomarkers results accompanying with other indexes in improving accurate diagnosis of AD. Methods: 112 AD patients and 30 cognitive normal controls were selected. Commercial accessible ELISA kits were introduced for measurement of CSF t-tau, p-tau181, A\u03b21\u201342, and NfL based on standard protocol. MRI examinations were performed using a 3-T MRI scanner and visual rating scales including medial temporal atrophy score and Koedam\u2019s scale were used to evaluate medial temporal atrophy and posterior region atrophy. Results: CSF biomarkers\u2019 profile including decreased concentration of A\u03b21\u201342, increased concentration of t-tau, p-tau181, t-tau\/A\u03b2 1\u201342, and NfL were diagnostic between AD and control. CSF biomarkers profile was not influenced by the APOE genotype. Increased concentration of t-tau and NfL, as well as ratio of t-tau\/A\u03b2 1\u201342 were related to decrease of Mini-Mental State Examination (MMSE) score while concentration of A\u03b21\u201342 not. Visual assessed cortical atrophy was related to MMSE score, but most of the CSF biomarkers were not related to atrophy, except that increased concentration of p-tau181 was significantly associated with atrophy of posterior cortical region. Conclusion: Our results supported CSF biomarkers were helpful in diagnosis of AD. However, CSF biomarkers were cross-sectional reflection of pathogenesis, which did not correlate well with clinical progression. CSF biomarkers should be interpreted in combination with MRI and cognitive evaluation in clinical use.<\/jats:p>","DOI":"10.3233\/jad-210344","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T13:56:49Z","timestamp":1621346209000},"page":"205-214","source":"Crossref","is-referenced-by-count":5,"title":["Relationship Between General Cognition, Visual Assessed Cortical Atrophy, and Cerebrospinal Fluid Biomarkers in Alzheimer\u2019s Disease: A Cross-Sectional Study from a Chinese PUMCH Cohort"],"prefix":"10.1177","volume":"82","author":[{"given":"Chenhui","family":"Mao","sequence":"first","affiliation":[{"name":"Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science\/Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longze","family":"Sha","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science\/Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinying","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science\/Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science\/Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Lei","sequence":"additional","affiliation":[{"name":"Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science\/Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science\/Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liling","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science\/Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caiyan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science\/Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Xu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science\/Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science\/Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-210344_ref1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: A systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-210344_ref2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11940-017-0484-z","article-title":"Current role for biomarkers in clinical diagnosis of Alzheimer disease and frontotemporal dementia","volume":"19","author":"Sheikh-Bahaei","year":"2017","journal-title":"Curr Treat Options Neurol"},{"key":"10.3233\/JAD-210344_ref3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-210344_ref4","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/ene.13945","article-title":"Clinical applicability of diagnostic biomarkers in early-onset cognitive impairment","volume":"26","author":"Falg\u00e1s","year":"2019","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-210344_ref5","first-page":"202","article-title":"Correlation of CSF- and MRI-biomarkers and progression of cognitive decline in an open label MCI trial","volume":"5","author":"Joachim","year":"2018","journal-title":"J Prev Alzheimers Dis"},{"key":"10.3233\/JAD-210344_ref6","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1212\/WNL.0b013e3181af79fb","article-title":"MRI and CSF biomarkers in normal, MCI, and AD subjects: Predicting future clinical change","volume":"73","author":"Vemuri","year":"2009","journal-title":"Neurology"},{"key":"10.3233\/JAD-210344_ref7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association Workgroups on Diagnostic Guidelines for Alzheimer\u2019s Disease","volume":"7","author":"Mckhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-210344_ref8","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3233\/JAD-141278","article-title":"Optimal cutoff scores for dementia and mild cognitive impairment of the Montreal Cognitive Assessment among elderly and oldest-old Chinese population","volume":"43","author":"Tan","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-210344_ref9","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/jnnp.55.10.967","article-title":"Atrophy of medial temporal lobes on MRI in \u201cprobable\u201d Alzheimer\u2019s disease and normal ageing: Diagnostic value and neuropsychological correlates","volume":"55","author":"Scheltens","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-210344_ref10","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1007\/s00330-011-2205-4","article-title":"Visual assessment of posterior atrophy development of a MRI rating scale","volume":"21","author":"Koedam","year":"2011","journal-title":"Eur Radiol"},{"key":"10.3233\/JAD-210344_ref11","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3233\/JAD-150238","article-title":"Alzheimer\u2019s disease cerebrospinal fluid and neuroimaging biomarkers: Diagnostic accuracy and relationship to drug efficacy","volume":"46","author":"Khan","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-210344_ref12","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3233\/JAD-141725","article-title":"Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer\u2019s disease from other dementias and healthy controls in the OPTIMA Cohort","volume":"44","author":"Seeburger","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-210344_ref13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jalz.2011.07.004","article-title":"Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer\u2019s disease diagnosis: A consensus paper from the Alzheimer\u2019s Biomarkers Standardization Initiative","volume":"8","author":"Vanderstichele","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-210344_ref14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer\u2019s Disease Neuroimaging Initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-210344_ref15","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/ana.21953","article-title":"Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease","volume":"67","author":"Vemuri","year":"2010","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-210344_ref16","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/archneur.55.7.937","article-title":"High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype","volume":"55","author":"Galasko","year":"1998","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-210344_ref17","doi-asserted-by":"crossref","DOI":"10.1177\/1759091419845524","article-title":"Higher level of mismatch in APOE\u025b4 carriers for amyloid-beta peptide Alzheimer\u2019s disease biomarkers in cerebrospinal fluid","volume":"11","author":"Vogelgsang","year":"2019","journal-title":"ASN Neuro"},{"key":"10.3233\/JAD-210344_ref18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13195-017-0313-3","article-title":"Preclinical effects of APOE \u025b4 on cerebrospinal fluid A\u03b242 concentrations","volume":"9","author":"Lautner","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-210344_ref19","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/j.neurobiolaging.2008.10.017","article-title":"Added diagnostic value of CSF biomarkers in differential dementia diagnosis","volume":"31","author":"Le Bastard","year":"2010","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-210344_ref20","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jamapsychiatry.2014.1060","article-title":"Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease","volume":"71","author":"Lautner","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.3233\/JAD-210344_ref21","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/archneurol.2011.123","article-title":"Longitudinal change of biomarkers in cognitive decline","volume":"68","author":"Lo","year":"2011","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-210344_ref22","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer\u2019s disease in patients with mild cognitive impairment: A follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-210344_ref23","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jns.2006.09.014","article-title":"CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment","volume":"251","author":"Stefani","year":"2006","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-210344_ref24","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0006-3223(99)00143-2","article-title":"Longitudinal stability of CSF tau levels in Alzheimer patients","volume":"46","author":"Sunderland","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-210344_ref25","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.neurobiolaging.2008.06.016","article-title":"Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: A longitudinal study","volume":"31","author":"Sluimer","year":"2010","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-210344_ref26","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ana.21223","article-title":"Beta-amyloid burden is not associated with rates of brain atrophy","volume":"63","author":"Josephs","year":"2008","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-210344_ref27","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/ana.22509","article-title":"Amyloid-\u03b2 associated volume loss occurs only in the presence of phospho-tau","volume":"70","author":"Desikan","year":"2011","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-210344_ref28","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.neurobiolaging.2011.02.022","article-title":"CSF tau markers are correlated with hippocampal volume in Alzheimer\u2019s disease","volume":"33","author":"De Souza","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-210344_ref29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000477718","article-title":"Visual ratings of medial temporal lobe atrophy correlate with CSF tau indices in clinical variants of early-onset Alzheimer disease","volume":"44","author":"Granadillo","year":"2017","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-210344_ref30","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/brain\/awp007","article-title":"MRI of hippocampal volume loss in early Alzheimer\u2019s disease in relation to APOE genotype and biomarkers","volume":"132","author":"Schuff","year":"2009","journal-title":"Brain"},{"key":"10.3233\/JAD-210344_ref31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1212\/WNL.0b013e31827b9147","article-title":"Can MRI screen for CSF biomarkers in neurodegenerative disease?","volume":"80","author":"Mcmillan","year":"2013","journal-title":"Neurology"},{"key":"10.3233\/JAD-210344_ref32","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s11682-012-9171-6","article-title":"CSF biomarker associations with change in hippocampal volume and precuneus thickness: Implications for the Alzheimer\u2019s pathological cascade","volume":"6","author":"Stricker","year":"2012","journal-title":"Brain Imaging Behav"},{"key":"10.3233\/JAD-210344_ref33","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.21559","article-title":"Decreased CSF A\u03b242 correlates with brain atrophy in cognitively normal elderly","volume":"65","author":"Fagan","year":"2009","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-210344_ref34","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0165-1781(03)00197-5","article-title":"Cerebrospinal fluid tau levels in Alzheimer\u2019s disease are elevated when compared with vascular dementia but do not correlate with measures of cerebral atrophy","volume":"120","author":"Sch\u00f6nknecht","year":"2003","journal-title":"Psychiatry Res"},{"key":"10.3233\/JAD-210344_ref35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3233\/JAD-2011-0006","article-title":"Relationship between CSF biomarkers of Alzheimer\u2019s disease and rates of regional cortical thinning in ADNI data","volume":"26","author":"Tosun","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-210344_ref36","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.neurobiolaging.2006.11.018","article-title":"CSF And MRI markers independently contribute to the diagnosis of Alzheimer\u2019s disease","volume":"29","author":"Schoonenboom","year":"2008","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-210344_ref37","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/j.neurobiolaging.2013.02.013","article-title":"Different patterns of gray matter atrophy in early- and late-onset Alzheimer\u2019s disease","volume":"34","author":"M\u00f6ller","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-210344_ref38","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.neuroimage.2012.04.056","article-title":"Combining MRI and CSF measures for classification of Alzheimer\u2019s disease and prediction of mild cognitive impairment conversion","volume":"62","author":"Westman","year":"2012","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-210344_ref39","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-210344_ref40","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jamaneurol.2015.3037","article-title":"Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression","volume":"73","author":"Zetterberg","year":"2016","journal-title":"JAMA Neurol"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-210344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:06:05Z","timestamp":1777370765000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-210344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,29]]},"references-count":40,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-210344","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,29]]}}}